Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

24,022 total articles

Metaplanet to Invest 2,100 Bitcoin in Super League to Launch U.S. Bitcoin Treasury Platform, Superplanet

Metaplanet to Invest 2,100 Bitcoin in Super League to Launch U.S. Bitcoin Treasury Platform, Superplanet

Metaplanet, a Tokyo-listed Bitcoin-focused company, will invest approximately $134.6 million in Super League Enterprise, Inc. (Nasdaq: SLE) by contributing 2,100 BTC and cash in exchange for a majority stake, resulting in renaming Super League to Superplanet, Inc. This creates a consolidated Bitcoin treasury platform spanning Nasdaq and Tokyo Stock…

TruGolf to Acquire Polymath Research Inc., Bringing Tokenization Innovator to the Public Markets on Nasdaq

TruGolf to Acquire Polymath Research Inc., Bringing Tokenization Innovator to the Public Markets on Nasdaq

TruGolf Holdings, Inc. announced the acquisition of Polymath Research Inc., a Canadian blockchain company specializing in regulated digital securities and tokenized financial instruments, to bring Polymath's Layer-1 blockchain technology to public markets via Nasdaq. This strategic move positions TruGolf at the forefront of the emerging tokenizatio…

Propanc Biopharma Clears Path for World-First Phase 1b Clinical Study of Breakthrough Cancer Therapy PRP

Propanc Biopharma Clears Path for World-First Phase 1b Clinical Study of Breakthrough Cancer Therapy PRP

Propanc Biopharma, Inc. announces the finalization of clinical trial protocols and feasibility assessments for its first-in-human Phase 1b study of PRP, an innovative cancer therapeutic targeting advanced solid tumors. The multi-center, open-label trial aims to evaluate safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary effic…

Pliant Therapeutics Receives FDA Fast Track Designation for PLN-101095 in Combination with Pembrolizumab for the Treatment of ICI-Refractory Solid Tumors

Pliant Therapeutics Receives FDA Fast Track Designation for PLN-101095 in Combination with Pembrolizumab for the Treatment of ICI-Refractory Solid Tumors

Pliant Therapeutics announced that the FDA has granted Fast Track designation for its investigational drug PLN-101095, combined with pembrolizumab, to treat solid tumors resistant to immune checkpoint inhibitors (ICI). PLN-101095 is an oral small molecule targeting integrins αvβ8 and αvβ1 and is currently in Phase 1a/1b clinical trials with data ex…

Cycurion Granted New Fleet Driver Analytics Patent, Opening a $100 Billion+ Telematics Market While Expanding Its Customer Base and Deepening Client Retention

Cycurion Granted New Fleet Driver Analytics Patent, Opening a $100 Billion+ Telematics Market While Expanding Its Customer Base and Deepening Client Retention

Cycurion, Inc. announced a newly granted U.S. patent on fleet driver analytics technology integrated into its Digital Ally platform. This innovation positions Cycurion to expand beyond public safety into the commercial trucking, logistics, and delivery fleet markets, tapping into the rapidly growing $100 billion global telematics industry. The tech…

Palm Technologies Selects SEALSQ Solutions to Bring Post-Quantum Hardware Security to India's Digital Payment, Public Transport and Connected Infrastructure Markets

Palm Technologies Selects SEALSQ Solutions to Bring Post-Quantum Hardware Security to India's Digital Payment, Public Transport and Connected Infrastructure Markets

SEALSQ Corp announced a strategic partnership with Palm Technologies to integrate its post-quantum hardware security technology QS7001 into Palm Technologies' biometric authentication products in India. This collaboration targets secure, quantum-resistant solutions for digital payments, public transport, defense communications, and connected infras…

Edible Garden Appoints Jon Gutoski as Chief Financial Officer

Edible Garden Appoints Jon Gutoski as Chief Financial Officer

Edible Garden AG Incorporated has appointed Jon Gutoski as its Chief Financial Officer, effective August 17, 2026, promoting him from his prior role as Controller. Gutoski brings extensive financial leadership experience and a deep understanding of the company's operations, positioning him to lead financial strategy and support growth initiatives. …

Barnes & Noble College First Day Complete® Expands to 263 Campuses Representing More Than 1.43 Million Students

Barnes & Noble College First Day Complete® Expands to 263 Campuses Representing More Than 1.43 Million Students

Barnes & Noble Education, Inc. announced the expansion of its First Day Complete® program through Barnes & Noble College, now offered at 263 college campuses across 40 states, covering more than 1.43 million students for the Fall 2026 term. The program integrates course material costs into tuition or course charges, delivering significant savings a…

Ming Shing Group Holdings Limited Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders’ Equity Requirement

Ming Shing Group Holdings Limited Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders’ Equity Requirement

Ming Shing Group Holdings Limited (NASDAQ: PMA), a Hong Kong-based wet trades services provider, announced that it received a notice from Nasdaq indicating non-compliance with minimum stockholders’ equity requirements due to reported net losses and comprehensive losses for recent fiscal years. The company must submit a compliance plan within 45 day…

Nanox and Vertec Scientific Enter Exclusive Sales Reseller Agreement for the Commercialization of Nanox.AI Bone Solution (HealthOST) in the United Kingdom

Nanox and Vertec Scientific Enter Exclusive Sales Reseller Agreement for the Commercialization of Nanox.AI Bone Solution (HealthOST) in the United Kingdom

Nanox Imaging Ltd., traded on NASDAQ as NNOX, announced that its subsidiary Nanox AI entered into an exclusive reseller agreement with UK-based Vertec Scientific for the commercialization of its AI-driven bone assessment software, Nanox.AI Bone Solution (HealthOST), in the United Kingdom. The three-year agreement includes minimum annual license com…

SciSparc: Subsidiary NeuroThera Labs Completes C$5.4 Million Financing with SciSparc’s Stake Valued at Approximately C$30 Million

SciSparc: Subsidiary NeuroThera Labs Completes C$5.4 Million Financing with SciSparc’s Stake Valued at Approximately C$30 Million

SciSparc Ltd., traded on Nasdaq as SPRC, announced that its majority-owned subsidiary NeuroThera Labs has completed a C$5.4 million private placement financing. SciSparc invested C$2.7 million, increasing its ownership to approximately 44.6% of NeuroThera, valuing its stake around C$30 million. NeuroThera plans to use proceeds for working capital a…

Trident Digital Tech Holdings (Nasdaq: TDTH) Executes Joint Venture to Deploy the IRMA AI Engine to Three Continents and Markets Representing Approximately 9.4 Million Businesses With Digital Innovations Group

Trident Digital Tech Holdings (Nasdaq: TDTH) Executes Joint Venture to Deploy the IRMA AI Engine to Three Continents and Markets Representing Approximately 9.4 Million Businesses With Digital Innovations Group

Trident Digital Tech Holdings announced a definitive joint venture agreement with U.S.-based Digital Innovations Group to establish IRMA Asia Pte. Ltd., a 50/50 joint venture deploying the IRMA AI Engine across Asia, the Middle East, and Africa. The venture targets approximately 9.4 million small and medium-sized businesses, aiming to commercialize…

Safe Pro Awarded Subcontract for Artificial Intelligence Powered Demining Software Under U.S. Department of State Program

Safe Pro Awarded Subcontract for Artificial Intelligence Powered Demining Software Under U.S. Department of State Program

Safe Pro Group Inc., a Nasdaq-listed AI defense technology firm, has been awarded a subcontract worth approximately $180,000 by the U.S. Department of State. The contract includes delivery of specialized AI-enabled GPU laptops equipped with the company's patented Spotlight OnSight software designed for explosive threat detection and mapping to supp…

Board-Certified Vascular and Endovascular Surgeon Performs First Commercial Symvess® Implantation; Cites Bioengineered Blood Vessel as “Revolutionary Advancement”

Board-Certified Vascular and Endovascular Surgeon Performs First Commercial Symvess® Implantation; Cites Bioengineered Blood Vessel as “Revolutionary Advancement”

Humacyte, a US-based biotech company, announced the first commercial implantations of Symvess, their FDA-approved bioengineered human blood vessel, performed by Dr. Jeromy Brink in Arizona. Symvess provides an off-the-shelf vascular graft option for emergency limb salvage surgeries, reducing the need for vein harvesting. This milestone marks a sign…

KabaFusion Selects CareCloud to Build First-of-Its-Kind Platform for Home Infusion and Specialty Pharmacy

KabaFusion Selects CareCloud to Build First-of-Its-Kind Platform for Home Infusion and Specialty Pharmacy

CareCloud, Inc. (Nasdaq: CCLD) has partnered with KabaFusion to co-develop LailaCare, a first-of-its-kind AI-powered integrated platform designed to streamline and modernize home infusion therapy workflows and specialty pharmacy services. The platform aims to unify referral intake, patient engagement, revenue cycle management, and operational effic…

Elutia Completes SimpliDerm® Sale on Schedule, Adds $8 Million in Cash to Fund NXT-41x Through Full Commercial Launch

Elutia Completes SimpliDerm® Sale on Schedule, Adds $8 Million in Cash to Fund NXT-41x Through Full Commercial Launch

Elutia Inc. has finalized the sale of its SimpliDerm human acellular dermal matrix business for up to $11 million, including an $8 million upfront payment. The transaction strengthens Elutia’s balance sheet with non-dilutive capital and enables the company to focus on developing and commercializing NXT-41x, an antibiotic-eluting biomatrix targeting…

Unusual Whales and Siebert Financial Announce Strategic Partnership to Launch New Series of ETFs

Unusual Whales and Siebert Financial Announce Strategic Partnership to Launch New Series of ETFs

Siebert Financial Corp. announced a strategic partnership with Unusual Whales to develop and launch new exchange-traded funds (ETFs) that leverage unique market intelligence such as political trading disclosures and unusual options activity. This collaboration combines Unusual Whales’ data access and community with Siebert’s financial expertise and…